Estudo de coorte prospectivo mostrou um risco de 3,1% de tromboembolismo venoso recorrente em 90 dias em pacientes com embolia pulmonar subsegmentar tratada sem anticoagulação.

Risk for Recurrent Venous Thromboembolism in Patients With Subsegmental Pulmonary Embolism Managed Without Anticoagulation: A Multicenter Prospective Cohort Study – Annals of Internal Medicine (link para o resumo – $ para o texto completo)

Comentário no Twitter

First prospective study including patients with isolated SSPE managed without anticoagulation published in @AnnalsofIM. Rate of recurrent VTE is 3.1% . Nice collaboration between @INNOVTE1 and @canvector funded by @HeartandStroke https://t.co/GdcbM1fRp1 @OttMethodsCentr

— Marc Carrier (@MarcCarrier1) November 23, 2021